We know that everyday studies are conducted against fighting cancer. Scientists are searching for cancer treatment, and at the Mount Sinai Hospital, researchers are developing a new immunotherapy process that could teach the immune system to destroy tumor cells.
Cancer is that process where abnormal cells are beginning to multiply the old cells are still there, but other cells are emerging. Those abnormal cells form tumors, and they are spreading in the body.
In this new study, scientists injected immune stimulants into the tumor cells for the stimulation of the immune system. After that, they saw that these stimulants have “recruited and instructed” the dendritic cells and T-cells. Those two types of cells are essential for the immune system; they could kill cancer cells and keep the healthy ones. What’s extraordinary is the fact that the immune cells have learned which type of cells they could kill and if they could continue to kill them throughout the body.
New Immunotherapy Process Could Teach the Immune System to Destroy Tumors
Moreover, they have tested it on human patients. The “in situ vaccination” was tested on patients with advanced-stage lymphoma, and the results had a good effect. Also, this new approach was combined with checkpoint blockade. Those checkpoint blockades are an immunotherapy option in which a drug blocks proteins. Proteins are the ones that slow down the killing of cancer cells.
Furthermore, this study and his successful results have caused other clinical trials for different types of cancers, like breast, neck, or head cancer. So the immunotherapy with the in situ vaccine will be used alongside with blockade drugs.
Finally, all the researchers are hoping that using and developing these combined methods and therapies could be applicable in the nearest future for all types of cancer and stop the causes of deaths worldwide.